AVITA Medical, Inc. (RCEL) Institutional Ownership

Ownership Summary

AVITA Medical, Inc. (NASDAQ:RCEL) appears in 67 institutional 13F filings for the quarter ending December 2025.

• Collectively, these holders controlled 15.9% of AVITA Medical's outstanding shares in December 2025, down from 18.5% in September 2025.
• They decreased total shares held in AVITA Medical by -1.64% from last quarter, and the number of investors in RCEL decreased 6.94% annually.
• Of these 67 funds, 21 grew their exposure to AVITA Medical, 30 cut back, and 16 maintained positions.
• The aggregate institutional position in AVITA Medical amounted to 4.84Mn shares as of December 2025, down by 80.7K shares quarter on quarter, and down 1.71Mn shares year over year.
• VANGUARD GROUP INC is the top holder of AVITA Medical as of December 31, 2025, with 1.44Mn shares representing 4.75% of outstanding stock.
• The most significant purchases of RCEL for the quarter ending December 2025 came from GEODE CAPITAL MANAGEMENT, LLC (147.72K), VANGUARD GROUP INC (79.1K), Morgan Stanley (52.47K), Aristides Capital LLC (27.8K), Jain Global LLC (24.17K).
• Top sellers of RCEL stock for the quarter ending December 2025 included Bank Of America Corp /De/ (98.95K), MILLENNIUM MANAGEMENT LLC (94.21K), JANE STREET GROUP, LLC (59.06K), BlackRock, Inc. (58.74K), Brooklyn Investment Group (44.21K).
• AVITA Medical's 10 largest shareholders as of December 2025 include VANGUARD GROUP INC (1.44Mn), BlackRock, Inc. (1.08Mn), GEODE CAPITAL MANAGEMENT, LLC (479.18K), State Street Corp (418.33K), Northern Trust Corp (163.4K), Morgan Stanley (149.72K), BRIDGEWAY CAPITAL MANAGEMENT, LLC (118.0K), AQR CAPITAL MANAGEMENT LLC (101.49K), Divisadero Street Capital Management, LP (100.0K), UBS Group AG (90.31K) per Business Quant data.